Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coenzyme A Technologies is a specialized healthcare company focused on the development and distribution of nutritional supplements centered on Coenzyme A (CoA). Known as the 'Master Enzyme,' CoA is a vital cofactor required for over 70% of all enzymatic reactions in the human body, particularly those involving energy metabolism and detoxification. The company offers proprietary formulations designed to support the Krebs cycle, fatty acid oxidation, and the synthesis of essential neurotransmitters. Their products are marketed to individuals seeking to optimize cellular energy, manage weight, and enhance athletic performance. Based in California, the company has been a pioneer in the application of CoA-based biochemistry for consumer health since the late 1990s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coenzyme A Technologies.